Á¦27ȸ ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2023-02-11±³À°ÀÏÀÚ : 2023-02-11
±³À°Àå¼Ò : ¼¿ï ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ
±³À°ÁÖÁ¦ :
Á¦27ȸ ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : AML/MDS¿¬±¸È¸
´ã´çÀÚ : Á¤¼¼¿µ
¿¬¶ôó : 02-533-1408
À̸ÞÀÏ :
ksh.amlmds.wp@gmail.com ±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-11 °Å¹®°íȦ 10:00~10:30 AML Oral Session Review 1 : Basic, Clinical and Epidemiological ÀåÁöÀº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-11 °Å¹®°íȦ 10:30~11:00 AML Oral Session Review 2 : Biomarker and MRD ±èÁøö(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 02-11 °Å¹®°íȦ 11:00~11:30 AML Oral Session Review 3 : Therapies ±èÁÖÇü(°æºÏÀÇ´ë)
½Ä»ç 02-11 °Å¹®°íȦ 11:30~12:30 ½Ä»ç ()
±³À°½Ã°£ 02-11 °Å¹®°íȦ 12:30~13:00 MDS Oral Session Review 1 : Basic and Translational À±¼®À±(¼øûÇâÀÇ´ë)
±³À°½Ã°£ 02-11 °Å¹®°íȦ 13:00~13:30 MDS Oral Session Review 2 : Clinical and Epidemiological ¾ÈÀç¼÷(Àü³²ÀÇ´ë)
±³À°½Ã°£ 02-11 °Å¹®°íȦ 13:30~14:00 MDS Education/Scientific program review °û´ëÈÆ(°¡Å縯ÀÇ´ë)
ÈÞ½Ä 02-11 °Å¹®°íȦ 14:00~14:15 Coffee break ()
±³À°½Ã°£ 02-11 °Å¹®°íȦ 14:15~14:45 How we diagnose AML/MDS in the era of precision medicine ±è¸í½Å(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02-11 °Å¹®°íȦ 14:45~15:15 How we test genetic mutations for target therapy Á¶¿µ¿í(¿ï»êÀÇ´ë)